Tmunity to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference

PHILADELPHIA--()--Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that President & CEO Usman “Oz” Azam will participate in a Fireside Chat at the 2020 RBC Capital Markets Healthcare Private Company Conference on Tuesday, December 15, 2020 at 11:20 am Eastern Time.

To access a live webcast of the Tmunity presentation, please visit: https://event.on24.com/wcc/r/2878699/563EFB4ED4795A423F474FB0CFF48FC3. Company presentations will be available to view on-demand via this same link within 24 hours of the session.

About Tmunity Therapeutics​

Tmunity is a private, clinical-stage biotherapeutics company, focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases. Integrating a foundational collaboration with the University of Pennsylvania (Penn), with groundbreaking scientific, clinical and manufacturing expertise, and the demonstrated track record of its founders (Carl June, MD; Bruce Levine, PhD; Yangbing Zhao, MD, PhD; Jim Riley, PhD; and Anne Chew, PhD), Tmunity represents a new center of gravity in translational T-cell medicine. Through Penn, the Parker Institute for Cancer Immunotherapy and other collaborations, Tmunity is developing a diversified portfolio of novel treatments that exhibit best-in-class control over T-cell activation and direction in the body, with a focus in cancer and two programs currently in clinic development.

With headquarters in Philadelphia, Tmunity utilizes laboratories and production facilities at Penn, and its own dedicated cGMP manufacturing facility in East Norriton, PA, to pursue process improvement and production scale-up in support of clinical development of its T-cell therapies. For more information, visit www.tmunity.com and connect with us on social media at @TmunityTx and LinkedIn.

Contacts

Julie Seidel
Stern Investor Relations
Julie.Seidel@sternir.com
212-362-1200

Contacts

Julie Seidel
Stern Investor Relations
Julie.Seidel@sternir.com
212-362-1200